Total Payments
$205,242
2024 Payments
$95,171
Companies
13
Transactions
118
Medicare Patients
254
Medicare Billing
$27,696
Payment Breakdown by Category
Consulting$171,506 (83.6%)
Other$17,550 (8.6%)
Travel$13,322 (6.5%)
Food & Beverage$1,923 (0.9%)
Research$940.00 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $171,506 | 44 | 83.6% |
| Travel and Lodging | $13,322 | 34 | 6.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,200 | 4 | 5.5% |
| Honoraria | $6,350 | 1 | 3.1% |
| Food and Beverage | $1,923 | 34 | 0.9% |
| Unspecified | $940.00 | 1 | 0.5% |
Payments by Type
General
$204,302
117 transactions
Research
$940.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $74,013 | 33 | $0 (2024) |
| GENZYME CORPORATION | $31,817 | 14 | $0 (2024) |
| Eli Lilly and Company | $26,425 | 19 | $0 (2024) |
| PFIZER INC. | $20,963 | 8 | $0 (2024) |
| ABBVIE INC. | $16,696 | 10 | $0 (2024) |
| Allergan, Inc. | $12,200 | 11 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $10,323 | 6 | $0 (2024) |
| Avita Medical Americas, Llc | $7,762 | 11 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $1,750 | 1 | $0 (2021) |
| Janssen Biotech, Inc. | $1,690 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $95,171 | 52 | GENZYME CORPORATION ($31,817) |
| 2023 | $55,207 | 39 | Incyte Corporation ($28,533) |
| 2022 | $40,989 | 18 | Incyte Corporation ($22,900) |
| 2021 | $12,491 | 5 | PFIZER INC. ($6,350) |
| 2020 | $1,335 | 1 | Allergan, Inc. ($1,335) |
| 2017 | $47.57 | 3 | Allergan Inc. ($33.73) |
All Payment Transactions
118 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $8,550.00 | General |
| 12/30/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $3,800.00 | General |
| 12/30/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $458.26 | General |
| 12/30/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $19.43 | General |
| 12/06/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $2,178.54 | General |
| 12/06/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $690.85 | General |
| 12/06/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $144.60 | General |
| 12/06/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $93.70 | General |
| 12/06/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $60.24 | General |
| 11/16/2024 | PFIZER INC. | LITFULO (Drug) | — | In-kind items and services | $940.00 | Research |
| Study: LITFULO CLINICAL PUBLICATION PROGRAM • Category: IMMUNOLOGY | ||||||
| 11/08/2024 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $15,375.00 | General |
| 11/08/2024 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $430.79 | General |
| 11/08/2024 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $263.01 | General |
| 11/08/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $220.97 | General |
| 11/08/2024 | GENZYME CORPORATION | — | Travel and Lodging | Cash or cash equivalent | $55.85 | General |
| 10/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $4,875.00 | General |
| 09/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Consulting Fee | Cash or cash equivalent | $1,650.00 | General |
| Category: Immunology | ||||||
| 09/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $39.90 | General |
| Category: Immunology | ||||||
| 09/14/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $8.44 | General |
| 09/13/2024 | Avita Medical Americas, Llc | Recell (Device) | Food and Beverage | Cash or cash equivalent | $61.53 | General |
| Category: Wound Care | ||||||
| 08/20/2024 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $5,320.00 | General |
| 08/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,125.00 | General |
| 08/02/2024 | Avita Medical Americas, Llc | Recell (Device) | Food and Beverage | Cash or cash equivalent | $28.67 | General |
| Category: Wound Care | ||||||
| 07/19/2024 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $6,800.00 | General |
| 07/11/2024 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $1,600.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| LITFULO CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $940.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 90 | 135 | $58,284 | $10,078 |
| 2022 | 3 | 65 | 104 | $42,025 | $7,907 |
| 2021 | 4 | 67 | 113 | $40,707 | $7,175 |
| 2020 | 2 | 32 | 50 | $17,750 | $2,536 |
Total Patients
254
Total Services
402
Medicare Billing
$27,696
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 67 | $26,800 | $4,710 | 17.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 25 | $13,375 | $2,816 | 21.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $8,400 | $1,468 | 17.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 12 | $3,300 | $652.11 | 19.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 12 | 17 | $6,409 | $431.82 | 6.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 39 | 71 | $28,400 | $5,358 | 18.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $8,400 | $1,472 | 17.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 19 | $5,225 | $1,078 | 20.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 22 | 53 | $21,200 | $4,288 | 20.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 20 | 33 | $9,075 | $1,875 | 20.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 11 | 11 | $4,400 | $616.02 | 14.0% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 14 | 16 | $6,032 | $396.64 | 6.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 17 | 32 | $12,800 | $1,908 | 14.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 15 | 18 | $4,950 | $627.16 | 12.7% |
About Dr. Nada Elbuluk, MD
Dr. Nada Elbuluk, MD is a Dermatology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2009. The National Provider Identifier (NPI) number assigned to this provider is 1013146307.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nada Elbuluk, MD has received a total of $205,242 in payments from pharmaceutical and medical device companies, with $95,171 received in 2024. These payments were reported across 118 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($171,506).
As a Medicare-enrolled provider, Elbuluk has provided services to 254 Medicare beneficiaries, totaling 402 services with total Medicare billing of $27,696. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Los Angeles, CA
- Active Since 07/07/2009
- Last Updated 11/27/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1013146307
Products in Payments
- LITFULO (Drug) $12,140
- Recell (Device) $7,762
- OPZELURA (Drug) $6,000
- OLUMIANT (Drug) $4,000
- TREMFYA (Drug) $3,440
- AKLIEF (Drug) $1,575
- CIBINQO (Drug) $72.57
- BOTOX CHRONIC MIGRAINE (Drug) $33.73
- COLLAGENASE SANTYL (Drug) $16.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Los Angeles
Christopher Ho, Md, MD
Dermatology — Payments: $929,207
Dermatology $929,207
Dr. Howard Sofen, M.d, M.D
Dermatology — Payments: $654,301
Dermatology $654,301
Jennifer Hsiao, M.d, M.D
Dermatology — Payments: $400,325
Dermatology $400,325
Dr. Pearl Grimes, Md, MD
Dermatology — Payments: $358,500
Dermatology $358,500
Derek Jones, Md, MD
Dermatology — Payments: $316,086
Dermatology $316,086
Rebecca Fitzgerald, M.d, M.D
Dermatology — Payments: $281,818
Dermatology $281,818